| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |